Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Astrocytoma × fluoromisonidazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 Glioblastoma 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage III Lung Non-Small Cell Cancer AJCC v7 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sarcoma 1 Melanoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Gliosarcoma 1 Glioma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 35 Radiotherapy 17 Bevacizumab 13 Magnetic Resonance Spectroscopy 9 Carmustine 9 Carboplatin 9 antineoplaston AS 2-1 8 antineoplaston A10 8 Irinotecan 7 Cyclophosphamide 6 Filgrastim 5 Cisplatin 5 sargramostim 4 Vincristine 4 Surgical Procedures, Operative 4 Specimen Handling 4 Everolimus 4 Etoposide 4 trametinib 3 Thalidomide 3 Sunitinib 3 Radiation 3 Procarbazine 3 Peripheral Blood Stem Cell Transplantation 3 Lomustine 3 FANG vaccine 3 Chemotherapy, Adjuvant 3 talampanel 2 palbociclib 2 dabrafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01868906 2018-08-24

FMISOPETSCS

Dr. Negrin University Hospital

Phase 2 Terminated

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡